Vascular Therapies
Vascular Therapies is a biotechnology company focused on improving patient outcomes by reducing surgical stenosis in patients with kidney and vascular disease. They have developed Sirogen™, an investigational sirolimus formulation for local, perivascular drug delivery, currently undergoing clinical trials to determine its safety and effectiveness in improving vascular access outcomes for hemodialysis patients.
Industries
Nr. of Employees
small (1-50)
Vascular Therapies
Cresskill, New Jersey, United States, North America
Patents
Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US-8858982-B2
View Details
Apparatus and methods for preventing or treating failure of hemodialysis vascular access and other vascular grafts
US-8858982-B2
View DetailsProducts
Bioresorbable sirolimus-eluting collagen implant for arteriovenous access
An investigational bioresorbable collagen-based implant that delivers sirolimus locally around the arteriovenous anastomosis to reduce intimal hyperplasia and help maintain fistula blood flow for hemodialysis.
Bioresorbable sirolimus-eluting collagen implant for arteriovenous access
An investigational bioresorbable collagen-based implant that delivers sirolimus locally around the arteriovenous anastomosis to reduce intimal hyperplasia and help maintain fistula blood flow for hemodialysis.
Services
Execution of a multicenter randomized clinical study to evaluate safety and effectiveness of a perivascular sirolimus-eluting collagen implant for arteriovenous fistula creation, including endpoint assessment and site coordination.
Preparation and dissemination of clinical and translational data through conference presentations and downloadable scientific materials.
Execution of a multicenter randomized clinical study to evaluate safety and effectiveness of a perivascular sirolimus-eluting collagen implant for arteriovenous fistula creation, including endpoint assessment and site coordination.
Preparation and dissemination of clinical and translational data through conference presentations and downloadable scientific materials.
Expertise Areas
- Vascular access therapeutics
- Perivascular/local drug delivery
- Clinical trial management for implantable devices (Phase III RCTs)
- Translational medicine (bench-to-bedside)
Key Technologies
- Bioresorbable collagen biomaterials
- Local sirolimus elution
- Perivascular drug-eluting implants
- Randomized controlled trial methodologies (Phase III)
News & Updates
November 4, 2021
February 11, 2020
November 4, 2021
February 11, 2020